naringenin has been researched along with ADPKD in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, HC; Chua, KH; Lim, SK; Mahendran, R; Ong, KC | 1 |
| Baines, D; Carew, MA; Dinh, C; Kuspa, A; Ludtmann, MH; Pakes, N; Robery, S; Waheed, A; Williams, RS | 1 |
1 review(s) available for naringenin and ADPKD
| Article | Year |
|---|---|
Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment.
Topics: Antioxidants; Chalcones; Curcumin; Diterpenes; Diterpenes, Kaurane; Emodin; Epoxy Compounds; Estrogen Antagonists; Flavanones; Humans; Hypoglycemic Agents; Metformin; Phenanthrenes; Plant Extracts; Polycystic Kidney, Autosomal Dominant; Protein Kinase Inhibitors; Quercetin; Resveratrol | 2021 |
1 other study(ies) available for naringenin and ADPKD
| Article | Year |
|---|---|
Naringenin inhibits the growth of Dictyostelium and MDCK-derived cysts in a TRPP2 (polycystin-2)-dependent manner.
Topics: Animals; Antiprotozoal Agents; Cell Proliferation; Dictyostelium; Dogs; Dose-Response Relationship, Drug; Flavanones; Kidney; Madin Darby Canine Kidney Cells; Mutation; Polycystic Kidney, Autosomal Dominant; Protozoan Proteins; RNA Interference; Time Factors; Transfection; TRPP Cation Channels | 2014 |